4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-23-000166
Chief Financial Officer gave up 2,569 shares (to pay taxes)
- Chief Financial Officer acquired 6,297 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Tsuchimoto Kim R · Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-12-31 | Exercise or conversion : show line 1 in the form | +5,067 | 19,846 | D | ||
| 2022-12-31 | Shares withheld for taxes : show line 2 in the form | −2,067 | $2.37 | $4,899 | 17,779 | D |
| 2023-01-01 | Exercise or conversion : show line 3 in the form | +1,230 | 19,009 | D | ||
| 2023-01-01 | Shares withheld for taxes : show line 4 in the form | −502 | $2.37 | $1,190 | 18,507 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-12-31 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −5,067 | 55,917 | D |
| 2023-01-01 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −1,230 | 1,231 | D |
Loading xslF345X03/rdgdoc.xml…